ILMN Share Price

Open 185.28 Change Price %
High 186.00 1 Day -4.39 -2.37
Low 180.78 1 Week 5.59 3.19
Close 180.89 1 Month 4.98 2.83
Volume 715934 1 Year 45.41 33.52
52 Week High 189.48
52 Week Low 119.37
ILMN Important Levels
Resistance 2 185.73
Resistance 1 183.73
Pivot 182.56
Support 1 178.05
Support 2 176.05
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.22 37.50%
FNFG 10.18 -0.20%
AVEO 1.95 56.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
More..
NASDAQ USA Top Gainers Stocks
AVEO 1.95 56.00%
LOCM 0.09 50.00%
DCTH 0.22 37.50%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
OPXAW 0.15 25.00%
PTSX 0.15 25.00%
FRED 12.61 23.02%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Illumina, Inc. (NASDAQ: ILMN)

ILMN Technical Analysis 4
As on 26th Jun 2017 ILMN Share Price closed @ 180.89 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 161.42 & Buy for SHORT-TERM with Stoploss of 178.54 we also expect STOCK to react on Following IMPORTANT LEVELS.
ILMN Target for June
1st Target up-side 186.7
2nd Target up-side 193.25
3rd Target up-side 199.8
1st Target down-side 168.02
2nd Target down-side 161.47
3rd Target down-side 154.92
ILMN Other Details
Segment EQ
Market Capital 5882942464.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.illumina.com
ILMN Address
ILMN
5200 Illumina Way
San Diego, CA 92122
United States
Phone: 858-202-4500
Fax: 858-202-4766
ILMN Latest News
Interactive Technical Analysis Chart Illumina, Inc. ( ILMN NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Illumina, Inc.
ILMN Business Profile
Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. The Company provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. Its Diagnostics business unit focuses on molecular diagnostics. In February 2014, Illumina, Inc. announced that Novogene purchased one HiSeq X Ten.